Immunity testing against COVID-19 from blood by an IoT-enabled and AI-controlled multiplexed microfluidic platform
Description
Developing herd immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is pivotal for changing the course of the coronavirus disease 2019 (COVID-19) pandemic. However, the uncertainty of vaccine-induced immunity development and
